Zenon Biosystem is a specialist Spanish company focused on developing a Methicillin-resistant Staphylococcus aureus (“MRSA”) detection device to be developed for use in hospitals.
MRSA is a bacterium responsible for several difficult-to-treat infections in humans. MRSA is a particular danger in clinical settings, such as hospitals and care homes.
There is currently no cost effective system that acts like a “Detector Alarm” for MRSA/SA, detecting infection early, in the patient or in the rooms of a healthcare building.
Zenon is developing unique technology to produce exactly such a device, utilizing a specialist team of scientists, mathematicians and engineers.
Zenon is a part of the Sgenia Group, a leading European sensor developer. Zenon is developing a “Zenosense MRSA Sensor” in collaboration with Zenosense Inc., a U.S. company who will have an exclusive, worldwide license on the resulting products, subject to certain limitations and a royalty arrangement on a revenue sharing basis with Zenon.